NCT05410912

Brief Summary

Varicose veins are a result of valvular insufficiency and presented with twisted, enlarged veins. They not only cause cosmetic concerns but also lead to limb edema, skin pigmentation/lipodermatosclerosis, and even venous ulcers. This disease affects a large percentage of the population. Although there have been several researches on the risk factors for varicose veins and the outcomes of alternative therapies , there is currently limited data focusing on varicose veins in young patients. In this case-control study, we wanted to assess the risk factors for varicose veins in patients under the age of 40, as well as their long-term results of surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 8, 2022

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

1.5 years

First QC Date

June 6, 2022

Last Update Submit

September 25, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative varicose veins sequelae

    The sequelae of the varicose vein were assessed by Venous Clinical Severity Score (VCSS). The total score is 0\~30. The higher scores mean a worse outcome.

    Five years after surgery.

  • Postoperative quality of life

    Quality of life was assessed by the Aberdeen Varicose Vein Questionnaire (AVVQ). The total score is 1\~100. The higher scores mean a worse outcome.

    Five years after surgery.

Study Arms (2)

The younger group

Patients who were under the age of 40

Procedure: Great saphenous vein stripping and ambulatory phlebectomy

The older group

Patients who were more than 40 years old

Procedure: Great saphenous vein stripping and ambulatory phlebectomy

Interventions

All patients included in the study were treated with great saphenous vein stripping and ambulatory phlebectomy.

The older groupThe younger group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with primary great saphenous varicose veins (GSVV) and treated by great saphenous vein stripping and ambulatory phlebectomy.

You may qualify if:

  • great saphenous varicose veins (GSVV) with saphenous vein reflux \>0.5s.
  • lower extremity venography excluding iliac vein compression;
  • treated by great saphenous vein stripping and ambulatory phlebectomy.
  • the patient had a minimum follow-up of five years.

You may not qualify if:

  • secondary varicose veins (defined as varicose veins caused by deep vein thrombosis, iliac venous compression or venous injury etc.);
  • small saphenous veins;
  • treated by endovenous ablation/laser or sclerotherapy alone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital, College of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310000, China

Location

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated chief physician

Study Record Dates

First Submitted

June 6, 2022

First Posted

June 8, 2022

Study Start

January 1, 2021

Primary Completion

June 30, 2022

Study Completion

December 30, 2024

Last Updated

September 27, 2024

Record last verified: 2024-09

Locations